Literature DB >> 15019072

Improvement of the ocular bioavailability of timolol by sorbic acid.

Masayo Higashiyama1, Katsuhiro Inada, Akira Ohtori, Kakuji Tojo.   

Abstract

The ocular bioavailability of timolol increased in sorbic acid solution due to ion pair formation. Its octanol/water partition coefficient also increased, suggesting the formation of a more lipophilic complex. The concentration of timolol in rabbit aqueous humor was determined after instillation of timolol ophthalmic solution containing sorbic acid. When the molar ratio of sorbic acid to timolol was two or higher, the concentration of timolol in the aqueous humor was higher than with timolol alone. In the presence of sorbic acid the maximal aqueous humor concentration and the area under the curve were more than two-fold higher than those of Timoptol, a timolol maleate ophthalmic solution, and similar in value to TIMOPTIC-XE, a gel-forming ophthalmic solution. To investigate the transcorneal absorption mechanism, in vitro permeation profiles across the intact and de-epithelialyzed cornea were analyzed on the basis of the bilayer diffusion model. The partition coefficient in the epithelium was about twice as high in the presence of sorbic acid than with timolol alone, although the diffusion coefficient in the epithelium did not change. We conclude that the improved ocular bioavailability in the presence of sorbic acid is due to increased partitioning of timolol in the corneal epithelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019072     DOI: 10.1016/j.ijpharm.2003.11.035

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  In vitro transport and partitioning of AL-4940, active metabolite of angiostatic agent anecortave acetate, in ocular tissues of the posterior segment.

Authors:  Paul Missel; James Chastain; Ashim Mitra; Uday Kompella; Viral Kansara; Sridhar Duvvuri; Aniruddha Amrite; Narayan Cheruvu
Journal:  J Ocul Pharmacol Ther       Date:  2010-04       Impact factor: 2.671

2.  Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection.

Authors:  Erin Lavik; Markus H Kuehn; Andrew J Shoffstall; Kristyn Atkins; Alina V Dumitrescu; Young H Kwon
Journal:  J Ocul Pharmacol Ther       Date:  2016-11-11       Impact factor: 2.671

3.  Development and characterization of 99mTc-timolol maleate for evaluating efficacy of in situ ocular drug delivery system.

Authors:  Himanshu Gupta; M Aqil; R K Khar; Asgar Ali; Aseem Bhatnagar; Gaurav Mittal; Sanyog Jain
Journal:  AAPS PharmSciTech       Date:  2009-05-08       Impact factor: 3.246

4.  Subconjunctival Delivery of Dorzolamide-Loaded Poly(ether-anhydride) Microparticles Produces Sustained Lowering of Intraocular Pressure in Rabbits.

Authors:  Jie Fu; Fengying Sun; Wenhua Liu; Yanfei Liu; Manasee Gedam; Qi Hu; Colleen Fridley; Harry A Quigley; Justin Hanes; Ian Pitha
Journal:  Mol Pharm       Date:  2016-07-07       Impact factor: 4.939

5.  Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery.

Authors:  Yangming Guo; Xing Liu; Xun Sun; Qiang Zhang; Tao Gong; Zhirong Zhang
Journal:  Theranostics       Date:  2012-11-19       Impact factor: 11.556

6.  Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide-maltodextrin complex.

Authors:  Ranjan Ku Sahoo; Nikhil Biswas; Arijit Guha; Nityananda Sahoo; Ketousetuo Kuotsu
Journal:  Acta Pharm Sin B       Date:  2014-09-04       Impact factor: 11.413

7.  Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.

Authors:  Masahiro Fuwa; Kenji Ueda; Takahiro Akaishi; Naoko Yamashita; Tomoko Kirihara; Atsushi Shimazaki; Hidetoshi Mano; Kouichi Kawazu
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.